• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Friday, September 29, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Algorithm that performs as accurately as dermatologists

Bioengineer by Bioengineer
February 12, 2021
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Photo: University of Gothenburg

A study has now been presented that boosts the evidence for using AI solutions in skin cancer diagnostics. With an algorithm they devised themselves, scientists at the University of Gothenburg show the capacity of technology to perform at the same level as dermatologists in assessing the severity of skin melanoma.

The study, published in the Journal of the American Academy of Dermatology, and its results are the work of a research group at the Department of Dermatology and Venereology at Sahlgrenska Academy, University of Gothenburg.

The study was conducted at Sahlgrenska University Hospital in Gothenburg. Its purpose was, through machine learning (ML), to train an algorithm to determine whether skin melanoma is invasive and there is a risk of it spreading (metastatizing), or whether it remains at a growth stage in which it is confined to the epidermis, with no risk of metastasis.

The algorithm was trained and validated on 937 dermatoscopic images of melanoma, and subsequently tested on 200 cases. All the cases included were diagnosed by a dermatopathologist.

The majority of melanomas are found by patients rather than doctors. This suggests that, in most cases, diagnosis is relatively easy. Before surgery, however, it is often much more difficult to determine the stage the melanoma has reached.

To make the classifications more accurate, dermatologists use dermatoscopes — instruments that combine a type of magnifying glass with bright illumination. In recent years, interest in using ML for skin tumor classifications has increased, and several publications have shown that ML algorithms can perform on par with, or even better than, experienced dermatologists.

The current study is now giving a further boost to research in this field. When the same classification task was performed by the algorithm on the one hand and seven independent dermatologists on the other, the result was a draw.

“None of the dermatologists significantly outperformed the ML algorithm,” states Sam Polesie, a researcher at the University of Gothenburg and specialist doctor at Sahlgrenska University Hospital, who is the corresponding author of the study.

In a developed form, the algorithm could serve as support in the task of assessing the severity of skin melanoma before surgery. The classification affects how extensive an operation needs to be, and is therefore important for both the patient and the surgeon.

“The results of the study are interesting, and the hope is that the algorithm can be used as clinical decision support in the future. But it needs refining further, and prospective studies that monitor patients over time are necessary, too,” Polesie concludes.

###

Title: Discrimination between Invasive and In situ Melanomas Using a Convolutional Neural Network,
https://www.jaad.org/article/S0190-9622(21)00336-4/fulltext

Title (supplementary text about the ML algorithm): Supplemental material — Discrimination between Invasive and In situ Melanomas Using a Convolutional Neural Network,
http://dx.doi.org/10.17632/y883xdgw86.1

Media Contact
Sam Polesie
[email protected]

Original Source

https://expertsvar.se/en/pressmeddelanden/algorithm-that-performs-as-accurately-as-dermatologists/

Related Journal Article

http://dx.doi.org/10.1016/j.jaad.2021.02.012

Tags: Algorithms/ModelscancerDermatologyDiagnosticsMedicine/HealthRobotry/Artificial Intelligence
Share12Tweet8Share2ShareShareShare2

Related Posts

Irritible Bowel Syndrome

New study will examine irritable bowel syndrome as long COVID symptom

September 29, 2023
Crystal Seldon Taswell, MD

ASTRO 2023 Session shines spotlight on physician burnout

September 29, 2023

American Academy of Arts and Sciences to induct UVA’s Garcia-Blanco

September 29, 2023

Study identifies new pathway to suppressing autoimmunity

September 29, 2023
Please login to join discussion

POPULAR NEWS

  • blank

    Microbe Computers

    59 shares
    Share 24 Tweet 15
  • A pioneering study from Politecnico di Milano sheds light on one of the still poorly understood aspects of cancer

    35 shares
    Share 14 Tweet 9
  • Fossil spines reveal deep sea’s past

    34 shares
    Share 14 Tweet 9
  • Scientists go ‘back to the future,’ create flies with ancient genes to study evolution

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New study will examine irritable bowel syndrome as long COVID symptom

True progression or pseudoprogression in glioblastoma patients?

Neural activity associated with motor commands changes depending on context

Subscribe to Blog via Email

Oops! It seems you have several subscriptions pending confirmation. You can confirm or unsubscribe some from the Subscriptions Manager before adding more.

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 56 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In